GLYALA Trademark

Trademark Overview

On Friday, March 18, 2016, a trademark application was filed for GLYALA with the United States Patent and Trademark Office. The USPTO has given the GLYALA trademark a serial number of 86945021. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 5, 2019. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The GLYALA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely, for use in slowing gastric emptying, improving glycemic control, increasing first-phase and second-phase insulin secretion, and in suppression of inappropriate glucagon secretion, and for the treatment and prevention of endocrine conditions and disorders, diabetes, diabetic complications, and hormonal diseases and disorders
glyala

General Information

Serial Number86945021
Word MarkGLYALA
Filing DateFriday, March 18, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 5, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely, for use in slowing gastric emptying, improving glycemic control, increasing first-phase and second-phase insulin secretion, and in suppression of inappropriate glucagon secretion, and for the treatment and prevention of endocrine conditions and disorders, diabetes, diabetic complications, and hormonal diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 23, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454

Trademark Events

Event DateEvent Description
Monday, August 5, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 5, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 15, 2019EXTENSION 5 GRANTED
Friday, January 4, 2019EXTENSION 5 FILED
Tuesday, January 15, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 4, 2019TEAS EXTENSION RECEIVED
Wednesday, July 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 2, 2018EXTENSION 4 GRANTED
Monday, July 2, 2018EXTENSION 4 FILED
Monday, July 2, 2018TEAS EXTENSION RECEIVED
Monday, July 2, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 19, 2017EXTENSION 3 GRANTED
Tuesday, December 19, 2017EXTENSION 3 FILED
Tuesday, December 19, 2017TEAS EXTENSION RECEIVED
Friday, June 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 28, 2017EXTENSION 2 GRANTED
Wednesday, June 28, 2017EXTENSION 2 FILED
Wednesday, June 28, 2017TEAS EXTENSION RECEIVED
Thursday, January 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 3, 2017EXTENSION 1 GRANTED
Tuesday, January 3, 2017EXTENSION 1 FILED
Tuesday, January 3, 2017TEAS EXTENSION RECEIVED
Tuesday, July 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 10, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, April 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 1, 2016ASSIGNED TO EXAMINER
Wednesday, March 23, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 22, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

glyala disorders pharmaceutical secretion phase prevention preparations namely treatment glucagon suppression